Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rate of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimens.

Journal of acquired immune deficiency syndromes (1999) - 1 May 2004

Kuritzkes Daniel R, Bassett Roland L, Hazelwood J Darren, Barrett Heidi, Rhodes Ruth A, Young Russell K, Johnson Victoria A

Abstract excerpt

Zidovudine (ZDV) and stavudine (d4T) select for the same set of thymidine analogue resistance mutations (TAMs). To compare the rate at which TAMs emerge, genotypic analysis of HIV-1 was performed on serial plasma samples from treatment-naive subjects randomly assigned to receive ZDV or d4T in com...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Multiple, Viral
Share to HIV-1
Share to HIV Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lamivudine

Share to Molecular Sequence Data

Share to Reverse Transcriptase Inhibitors

Share to Stavudine

Share to Zidovudine

Source

Identifiers

PMID: 15097303
DOI: 10.1097/00126334-200405010-00008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-15097303-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rate of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimens.PMID 15097303Read ↗

Thymidine-analog and multi-nucleoside resistance mutations are observed in both zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens.Semantic proximity Read ↗

Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine.Semantic proximity Read ↗

Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapy.Semantic proximity Read ↗

Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy.Semantic proximity Read ↗

Rate of Accumulation of Thymidine Analogue Mutations in Patients Continuing to Receive Virologically Failing Regimens Containing Zidovudine or Stavudine: Implications for Antiretroviral Therapy Programs in Resource‐Limited SettingsSemantic proximity Read ↗

Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure.Semantic proximity Read ↗

Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.Semantic proximity Read ↗

Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.Semantic proximity Read ↗

Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.Semantic proximity Read ↗

Evolution of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients.Semantic proximity Read ↗

The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients.Semantic proximity Read ↗

Fitness Comparison of Thymidine Analog Resistance Pathways in Human Immunodeficiency Virus Type 1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.